Healthcare Innovation: MedTech Giants Portfolio 2025
Growing demand for advanced healthcare in Africa highlights the global companies at the forefront of medical technology innovation. This theme offers exposure to US and EU-listed industry leaders in robotic surgery, diagnostic imaging, and other medical devices.
About This Group of Stocks
Our Expert Thinking
This group captures the long-term growth potential of global healthcare technology, driven by ageing populations, rising chronic disease rates, and continuous medical innovation. By focusing on established leaders in robotic surgery, diagnostic imaging, and medical devices, we're targeting companies at the forefront of life-saving technological advancement.
What You Need to Know
These are defensive, high-growth companies that benefit from consistent healthcare demand regardless of economic cycles. The group includes both innovative technology pioneers and established medical device conglomerates, providing a balanced mix of growth potential and stability in a sector that's essential to human wellbeing.
Why These Stocks
Each company was selected for its leadership position in the global medical technology supply chain. From robotic surgery innovators to diagnostic imaging giants, these firms dominate their respective niches and are well-positioned to benefit from the relentless pace of healthcare innovation and growing global medical device demand.
Why You'll Want to Watch These Stocks
Innovation That Saves Lives
These companies are pioneering breakthrough technologies like robotic surgery and AI-powered diagnostics that are revolutionising healthcare. As medical technology advances, early investors could benefit from the massive market potential.
Global Healthcare Boom
With ageing populations worldwide and rising healthcare spending, these medical technology leaders are positioned to capture growing demand. The sector offers defensive growth that's less sensitive to economic downturns.
Quality Companies, Proven Track Records
These aren't speculative bets but established industry giants with decades of innovation and consistent profitability. Many pay dividends whilst continuing to invest heavily in research and development.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Small Cap Index: Could Africa Growth Unlock Value?
Africa's expanding economies are powered by a new generation of growing companies and rising consumer demand. This basket offers exposure through global companies that provide market access, financial tools, and essential services fueling this growth.
MASH Stocks: Could Roche's Deal Spark More M&A?
Roche's $3.5 billion acquisition of 89bio for its liver disease drug highlights the growing MASH treatment market. This deal creates a potential tailwind for other biopharmaceutical companies developing therapies for liver and metabolic conditions.
AI Chip Stocks: Intel-Nvidia Deal Risks & Rewards
Nvidia announced a $5 billion investment in Intel, marking a major collaboration between the two semiconductor rivals to develop new AI and data center technologies. This partnership could create a ripple effect, boosting companies that supply essential hardware and software for the expanding AI infrastructure ecosystem.
Frequently Asked Questions
Everything you need to know about the product and billing.